3-8771545-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000472766.1(CAV3):​n.156-5932G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0638 in 152,172 control chromosomes in the GnomAD database, including 323 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.064 ( 323 hom., cov: 33)

Consequence

CAV3
ENST00000472766.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.165

Publications

15 publications found
Variant links:
Genes affected
CAV3 (HGNC:1529): (caveolin 3) This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008]
CAV3 Gene-Disease associations (from GenCC):
  • caveolinopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant limb-girdle muscular dystrophy type 1C
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • long QT syndrome 9
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rippling muscle disease 2
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • distal myopathy, Tateyama type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • inherited rippling muscle disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Brugada syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • hypertrophic cardiomyopathy 1
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia
  • long QT syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000472766.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAV3
ENST00000472766.1
TSL:2
n.156-5932G>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0638
AC:
9702
AN:
152054
Hom.:
324
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0607
Gnomad AMI
AF:
0.0198
Gnomad AMR
AF:
0.0608
Gnomad ASJ
AF:
0.114
Gnomad EAS
AF:
0.111
Gnomad SAS
AF:
0.0571
Gnomad FIN
AF:
0.0308
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0659
Gnomad OTH
AF:
0.0742
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0638
AC:
9706
AN:
152172
Hom.:
323
Cov.:
33
AF XY:
0.0621
AC XY:
4621
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0606
AC:
2516
AN:
41522
American (AMR)
AF:
0.0608
AC:
928
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.114
AC:
396
AN:
3470
East Asian (EAS)
AF:
0.111
AC:
574
AN:
5176
South Asian (SAS)
AF:
0.0576
AC:
278
AN:
4828
European-Finnish (FIN)
AF:
0.0308
AC:
326
AN:
10586
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0659
AC:
4480
AN:
68002
Other (OTH)
AF:
0.0754
AC:
159
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
470
941
1411
1882
2352
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0652
Hom.:
36
Bravo
AF:
0.0657
Asia WGS
AF:
0.0850
AC:
293
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
2.4
DANN
Benign
0.62
PhyloP100
-0.17

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1488467; hg19: chr3-8813231; API